1. Home
  2. OGCP vs DMAC Comparison

OGCP vs DMAC Comparison

Compare OGCP & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGCP
  • DMAC
  • Stock Information
  • Founded
  • OGCP N/A
  • DMAC 2000
  • Country
  • OGCP
  • DMAC United States
  • Employees
  • OGCP 667
  • DMAC N/A
  • Industry
  • OGCP
  • DMAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • OGCP
  • DMAC Health Care
  • Exchange
  • OGCP NYSE
  • DMAC Nasdaq
  • Market Cap
  • OGCP 2.3B
  • DMAC 178.0M
  • IPO Year
  • OGCP N/A
  • DMAC N/A
  • Fundamental
  • Price
  • OGCP N/A
  • DMAC $3.76
  • Analyst Decision
  • OGCP
  • DMAC Strong Buy
  • Analyst Count
  • OGCP 0
  • DMAC 2
  • Target Price
  • OGCP N/A
  • DMAC $8.00
  • AVG Volume (30 Days)
  • OGCP N/A
  • DMAC 307.4K
  • Earning Date
  • OGCP N/A
  • DMAC 08-06-2025
  • Dividend Yield
  • OGCP N/A
  • DMAC N/A
  • EPS Growth
  • OGCP N/A
  • DMAC N/A
  • EPS
  • OGCP N/A
  • DMAC N/A
  • Revenue
  • OGCP N/A
  • DMAC N/A
  • Revenue This Year
  • OGCP N/A
  • DMAC N/A
  • Revenue Next Year
  • OGCP N/A
  • DMAC N/A
  • P/E Ratio
  • OGCP N/A
  • DMAC N/A
  • Revenue Growth
  • OGCP N/A
  • DMAC N/A
  • 52 Week Low
  • OGCP N/A
  • DMAC $2.80
  • 52 Week High
  • OGCP N/A
  • DMAC $6.82
  • Technical
  • Relative Strength Index (RSI)
  • OGCP 60.53
  • DMAC 47.18
  • Support Level
  • OGCP $7.80
  • DMAC $3.48
  • Resistance Level
  • OGCP $8.75
  • DMAC $3.99
  • Average True Range (ATR)
  • OGCP 0.07
  • DMAC 0.32
  • MACD
  • OGCP -0.02
  • DMAC -0.00
  • Stochastic Oscillator
  • OGCP 63.16
  • DMAC 41.01

About OGCP EMPIRE STATE REALTY OP LIM PARTNER

Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.

Share on Social Networks: